Skin Elements Clears Regulatory Hurdle Before Board Spill Vote
Takeovers Panel clears path for Skin Elements after 62 Capital undertaking
The Takeovers Panel has declined to conduct proceedings against Skin Elements Limited (ASX: SKN) following an application lodged by the company on 25 May 2026. The Panel accepted an undertaking from 62 Capital Pty Ltd, signed 1 June 2026, and concluded there was no reasonable prospect it would make a declaration of unacceptable circumstances. The resolution removes regulatory uncertainty for Skin Elements and its shareholders ahead of upcoming board spill meetings.
The sitting Panel comprised Marina Kelman, Jeremy Leibler (sitting President), and Christopher Stavrianou.
What triggered the application
Skin Elements applied to the Panel alleging an association between 62 Capital and certain placement investors, with the application arising in the context of upcoming board spill meetings. 62 Capital served as lead manager to Skin Elements’ $2.5 million placement announced on 15 October 2025.
The placement was structured as a two-tranche private placement to professional and sophisticated investors, with the following terms:
- Raise amount: $2.5 million (before costs)
- Tranche 1: 1,250,000,000 shares at $0.002 per share
- Options: 625,000,000 unlisted options (one per every two shares issued), each exercisable at $0.006 per share
When big ASX news breaks, our subscribers know first
Understanding the Takeovers Panel and why it matters for ASX investors
The Takeovers Panel is an independent Australian government body that acts as the primary forum for resolving disputes about control transactions involving listed companies. It is not a court, but it has the authority to declare circumstances “unacceptable” where conduct threatens the integrity of the market for corporate control, even if that conduct technically complies with the law.
The Panel typically becomes involved when issues arise around voting power, share register integrity, or compliance with Chapters 6 and 6C of the Corporations Act 2001. These chapters govern concepts such as “relevant interest” (the threshold at which a person is considered to control or influence securities) and associated disclosure obligations. When two or more parties are alleged to be associates, their combined voting power is aggregated, potentially triggering takeover thresholds without proper disclosure.
In the context of a board spill, this matters because undisclosed associations could influence the outcome of shareholder votes. A Panel inquiry creates uncertainty around who effectively controls securities on the register. A clean resolution, as achieved here, restores clarity and confirms that placement investors are free to act independently.
The Clause 7 issue explained
The Panel’s review identified a specific concern within the subscription agreements entered into between 62 Capital and each placement investor. Clause 7 of those agreements prohibited placement investors from transferring or dealing with their placement securities without 62 Capital’s consent.
The Panel considered that if Clause 7 operated as a continuing restriction on the transfer or disposal of placement securities after issue, it could give rise to concerns under Chapters 6 and 6C of the Corporations Act, including as to whether 62 Capital held a “relevant interest” in those securities. The Panel was, however, inclined to the view that Clause 7 was not intended to have that effect, having regard to 62 Capital’s submissions and the context of the subscription agreements.
The undertaking resolved the concern regardless of that interpretation.
Panel conclusion
“The Panel concluded there was no reasonable prospect that it would make a declaration of unacceptable circumstances.”
What the 62 Capital undertaking means in practice
Under the undertaking signed on 1 June 2026, 62 Capital committed to the following obligations:
- Not enforce or exercise its rights under Clause 7 (Allocation Personal – Placement Shares) of the Subscription Agreements
- Treat Clause 7 as waived from the date of the undertaking, pursuant to Clause 8(c) (General) of the Subscription Agreements
- Write to each Placement Investor as soon as practicable, releasing them from Clause 7 (Allocation Personal – Placement Shares)
- Confirm in writing to the Panel once the obligations under point 3 are satisfied
The Panel determined that the undertaking “adequately addressed its concerns by removing any restriction or potential restriction under clause 7 of the subscription agreements on the transfer or disposal of Placement Securities after issue.”
| Party | Role | Action | Outcome |
|---|---|---|---|
| Skin Elements (ASX: SKN) | Applicant | Filed Panel application 25 May 2026 | Proceedings declined |
| 62 Capital Pty Ltd | Lead Manager / Respondent | Signed undertaking 1 June 2026 | Clause 7 waived; investors released |
| Placement Investors | Security holders | Recipients of Clause 7 release letter | Free to transfer placement securities |
| Takeovers Panel | Regulator | Reviewed undertaking | No declaration of unacceptable circumstances |
Association claim did not meet the threshold
As a secondary finding, the Panel noted that insufficient evidence had been provided to support Skin Elements’ submission that 62 Capital and the placement investors were acting in concert as associates. This finding did not form the basis for the Panel’s decision to decline proceedings; the accepted undertaking was the operative resolution. The association allegation, on its own, did not warrant further enquiries.
The next major ASX story will hit our subscribers first
What this resolution means for Skin Elements shareholders
The Panel process has concluded without adverse findings, and no declaration of unacceptable circumstances was made. Placement investors are now released from any restriction on transferring their securities, providing clarity across the share register at a sensitive point for the company.
The Panel will publish its full reasons for the decision in due course on its website at **www.takeovers.gov.au**. Given that the original application arose in the context of upcoming board spill meetings, investors should continue to monitor any further announcements relating to board composition and shareholder meeting outcomes at Skin Elements.
Don’t Miss the Next Consumer Sector Move on ASX
Big News Blast delivers FREE breaking ASX announcements straight to your inbox within minutes of release, complete with in-depth analysis already done for you. Over 20,000 active subscribers stay ahead of the market with real-time alerts across consumer, tech, healthcare and more. Click the “Free Alerts” button to start receiving the news the moment it breaks.